Abbott Laboratories operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Abbott Laboratories with three other
companies in this sector in the United States:
sales of $22.86 billion
of which 100%
was Pharmaceutical Products),
Eli Lilly and Company
of which 35%
was Endocrinology), and
Teva Pharmaceutical Industries Limited
of which 49%
was Generic Madicines).
During the year ended December of 2015, sales at
Abbott Laboratories were $20.41 billion.
a very small
increase of 0.8%
versus 2014, when the company's sales were $20.25 billion.
Despite this increase, sales are still
below the level achieved in 2013, when Abbott Laboratories
reported sales of $21.85 billion.
Sales of Established Pharmaceutical Products saw an increase
that was more than double the company's growth rate: sales were up
19.3% in 2015, from
$3.12 billion to $3.72 billion.
Not all segments of Abbott Laboratories experienced an increase in sales in 2015:
sales of Other fell 8.0% to $2.27 billion.
Abbott Laboratories also experienced decreases in sales in
Diagnostics Products (down 1.6% to $4.65 billion)
Vascular Products (down 6.5% to $2.79 billion)